Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline
Connie B. Newman(New York University), Lisa R. Tannock(University of Kentucky), Henry N. Ginsberg(Columbia University), Michael J. Blaha(University of Vermont), Alan Chait(University of Washington), Jeffrey B. Boord(Parkview Health), M. Hassan Murad(Mayo Clinic), Savitha Subramanian(Gates Foundation), Henry G. Fein(Sinai Hospital), Ira J. Goldberg(New York University), Bertrand Cariou(Institut du Thorax)
Cited by 147
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Prevention of VTE in Nonsurgical Patients
|CHEST Journal|2012|2.7k
Global vascular guidelines on the management of chronic limb-threatening ischemia
|Journal of Vascular Surgery|2019|1.9k
Triglycerides and Cardiovascular Disease
|Circulation|2011|1.9k